Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-14

Clinical Trial Update: Norepinephrine to Prevent Hypotension in Ceasrean Delivery [Phase 4]

View source ↗

Summary

Phase 4 trial updating the use of norepinephrine to prevent hypotension during cesarean delivery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

Snippet

Sponsor: Menoufia University | Conditions: Hypotension, Cesarean Section Complications | Phase 4 | Status: COMPLETED